We are live on
!
Find out more
RP
Riverbridge Partners Portfolio holdings
AUM
$3.58B
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
-0.02%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.53B
AUM Growth
+$10.1M
(+0.18%)
Cap. Flow
+$62.9M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
130
New
4
Increased
67
Reduced
44
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dorman Products
DORM
|
+$38.4M |
| 2 |
Healthcare Services Group
HCSG
|
+$28.6M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$20.9M |
| 4 |
ECOM
CHANNELADVISOR CORPORATION
ECOM
|
+$15.5M |
| 5 |
TTSH
Tile Shop Holdings
TTSH
|
+$13.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$65.4M |
| 2 |
CoStar Group
CSGP
|
+$41.9M |
| 3 |
Perrigo
PRGO
|
+$26.9M |
| 4 |
Bio-Techne
TECH
|
+$20.1M |
| 5 |
Medtronic
MDT
|
+$2.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.65% |
| 2 | Industrials | 18.83% |
| 3 | Healthcare | 15.77% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Consumer Staples | 6.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wells Fargo
WFC
$254B
| $751K | 0.01% |
15,098
-1,672
| -10% | -$77.9K |
|
|
QGENF
102
DELISTED
QIAGEN NV
QGENF
| $655K | 0.01% |
31,060
+16,700
| +116% | +$352K |
|
103
PACCAR
PCAR
$70.5B
| $634K | 0.01% |
+14,099
| New | +$581K |
|
104
iShares Russell 1000 ETF
IWB
$47.1B
| $549K | 0.01% |
5,239
+254
| +5% | +$26.1K |
|
105
iShares Russell Mid-Cap ETF
IWR
$55.9B
| $517K | 0.01% |
13,360
-24
| -0.2% | -$910 |
|
106
Invesco S&P 500 Pure Growth ETF
RPG
$1.9B
| $512K | 0.01% |
34,980
| – | – |
|
107
iShares Russell 1000 Growth ETF
IWF
$117B
| $503K | 0.01% |
23,252
| – | – |
|
108
ExxonMobil
XOM
$650B
| $472K | 0.01% |
4,835
-92
| -2% | -$8.77K |
|
109
iShares Core S&P 500 ETF
IVV
$858B
| $460K | 0.01% |
2,446
-8,151
| -77% | -$1.51M |
|
110
Pfizer
PFE
$143B
| $446K | 0.01% |
14,644
| – | – |
|
111
General Mills
GIS
$20.2B
| $396K | 0.01% |
7,634
| – | – |
|
112
Philips
PHG
$25.5B
| $332K | 0.01% |
13,616
-5,957
| -30% | -$146K |
|
113
iShares Russell 1000 Value ETF
IWD
$81.4B
| $314K | 0.01% |
3,252
+35
| +1% | +$3.28K |
|
|
BMS
114
DELISTED
Bemis
BMS
| $252K | ﹤0.01% |
6,419
-870
| -12% | -$33.9K |
|
|
STJ
115
DELISTED
St Jude Medical
STJ
| $227K | ﹤0.01% |
3,478
| – | – |
|
116
Berkshire Hathaway Class B
BRK.B
$1.1T
| $225K | ﹤0.01% |
1,797
| – | – |
|
117
Boeing
BA
$169B
| $215K | ﹤0.01% |
1,717
| – | – |
|
118
Oracle
ORCL
$339B
| $205K | ﹤0.01% |
+5,000
| New | +$190K |
|
119
IBM
IBM
$213B
| – | – |
-1,540
| Closed | -$276K |
|
Similar funds
BPS
VPC
WWA
SPC
U
SL
SCM
AAP
Riverbridge Partners's Q1 2014 Portfolio in Review
As of Q1 2014, Riverbridge Partners held 130 positions worth $5.53B, up 0.18% from $5.52B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Trading was light in Q1 2014: portfolio turnover was 4.6%. Riverbridge Partners opened 4 new positions and exited 2, leaving the 130-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.
- Riverbridge Partners's largest Q1 2014 buy was Dorman Products: 699,282 shares worth $41.3M.
- Riverbridge Partners added most to Linear Technology Corp in Q1 2014, an estimated $20.9M increase.
- Riverbridge Partners's biggest Q1 2014 reduction was Athenahealth, Inc., cutting an estimated $65.4M.
- Riverbridge Partners fully exited IBM in Q1 2014, selling an estimated $276K.
- Riverbridge Partners's ten largest holdings make up 29% of its $5.53B portfolio in Q1 2014.
- Riverbridge Partners opened 4 new positions and closed 2 in Q1 2014.
- Riverbridge Partners's portfolio value rose 0.18% quarter-over-quarter to $5.53B.
Based on Riverbridge Partners's 13F filing for Q1 2014, filed 9 May 2014.